SCHEMBL3339558

SCHEMBL3339558

CCCCCc1cc2c(nc(O)n2CC2CCN(C(=O)OC(C)(C)C)CC2)c(N(Cc2ccc(OC)cc2)Cc2ccc(OC)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.42
BACE1 P56817 1/20 0.41
HTT P42858 2/20 0.41
P2RX3 P56373 2/20 0.41
PIK3CA P42336 1/20 0.41
PRKDC P78527 1/20 0.41
RORC P51449 1/20 0.40
TP53 P04637 5/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
LMNA P02545 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TSHR P16473 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
HSD17B10 Q99714 1/20 0.39
BMP1 P13497 1/20 0.38
TGFBR1 P36897 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL563312 0.80 DYRK1A (0.43) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL562970 0.80 SLC2A1 (0.43) SLC2A1BACE1HTTTP53ALDH1A1
SCHEMBL562610 0.78 SLC2A1 (0.42) SLC2A1BACE1HTTTP53ALDH1A1
SCHEMBL563383 0.76 TLR7 (0.45) HTTTP53ALDH1A1HPGDKMT2A
SCHEMBL562921 0.76 KCNH2 (0.41) TP53LMNAMEN1KMT2ATSHR
SCHEMBL562152 0.75 TP53 (0.35) TP53LMNATSHR
SCHEMBL561914 0.73 TLR7 (0.39) HTTALDH1A1KDM4ELMNAMEN1
SCHEMBL563640 0.72 SLC2A1 (0.41) SLC2A1BACE1HTTTP53ALDH1A1
SCHEMBL28507097 0.71 MMP13 (0.40) SLC2A1HTTTP53ALDH1A1KDM4E
SCHEMBL563410 0.70 CNR2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152230-A1 HYDROXY SUBSTITUTED 1H-IMIDAZOPYRIDINES AND METHODS PFIZER INC. 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152230-A1 HYDROXY SUBSTITUTED 1H-IMIDAZOPYRIDINES AND METHODS IL4, IL2, IL4I1 SLC2A1 4811/4885BACE1 4738/4885HTT 1555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.